AnHeart Therapeutics
Precision medicine biopharmaceutical company leveraging expertise in clinical research and development and product registration focusing initially on oncology products. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€222—333m (Dealroom.co estimates Dec 2021.)
Shanghai Shanghai (HQ)
Authorizing premium user...